New troponin doubles low-risk picks

Troponin is the protein heart muscle leaks into blood when it is injured, and a new sixth-generation test picked out nearly half of chest-pain patients as low risk on arrival. (jamanetwork.com) In the JAMA Cardiology study, researchers tested 987 adults with possible non–ST-segment elevation myocardial infarction and compared the new assay head-to-head with the current fifth-generation troponin T test on the same analyzer. (jamanetwork.com) The paper, published online April 22, 2026, found that an early rule-out pathway with the new assay would have classified almost one-half of patients as low risk at presentation, versus about one-fifth with guideline-recommended approaches using the current assay. (jamanetwork.com) Emergency departments already use high-sensitivity troponin to decide who can go home after one blood draw and who needs repeat testing, observation, or admission. The goal is to miss as few heart attacks as possible while avoiding hours of extra monitoring for patients whose risk is very low. (jamanetwork.com) The study set its safety bar at a negative predictive value of at least 99.5% and sensitivity of at least 99% for myocardial infarction or cardiac death at 30 days. Those are the kinds of thresholds clinicians use when a “rule-out” test is meant to reassure doctors that discharge is safe. (jamanetwork.com) The current Roche high-sensitivity troponin T assay has long used very low cutoffs near its detection floor, with 5 ng/L used outside the United States and 6 ng/L used in the United States after Food and Drug Administration reporting rules blocked exact values below the limit of quantitation. (jamanetwork.com) The new assay matters because it measures tiny troponin concentrations more precisely, which lets researchers derive a single-sample “very low-risk” threshold that is less tied to the quirks of the assay’s detection limit. (jamanetwork.com) That could change patient flow in crowded emergency departments. A 2024 Lancet Regional Health–Europe study found that even when high-sensitivity troponin identified about half of patients with possible myocardial infarction as low risk, only about two-thirds of those patients were actually discharged, with wide variation by site, age, ethnicity, and deprivation. (thelancet.com) A separate validation study published April 20, 2026, in European Heart Journal: Acute Cardiovascular Care also reported strong performance for the new assay: in 1,415 patients, a 0/1-hour algorithm ruled out myocardial infarction in 54.3% with a 99.5% negative predictive value. (academic.oup.com) The JAMA Cardiology authors did not show that hospitals using the new test have already cut admissions or shortened stays; the editorial alongside the paper said implementation studies are still needed. For now, the result is a cleaner first-pass screen for one of the most common and costly problems in emergency medicine. (jamanetwork.com)